PSI Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
PSI Advisors's GILD Position: Q2 2025 in Review
PSI Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 568 shares — an estimated $63.6K sold.
PSI Advisors first reported a position in GILD in Q4 2019 and held it in 22 quarters. The position peaked at $778K in Q4 2021. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- PSI Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- PSI Advisors sold 568 Gilead Sciences shares in Q2 2025, an estimated $63.6K.
- PSI Advisors first reported a position in Gilead Sciences in Q4 2019 and held it in 22 quarters.
- PSI Advisors's Gilead Sciences position peaked at $778K in Q4 2021.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.